Skip NavigationSkip to Content

Xeroderma pigmentosum-variant patients from America, Europe, and Asia

  1. Author:
    Inui, H.
    Oh, K. S.
    Nadem, C.
    Ueda, T.
    Khan, S. C.
    Metin, A.
    Gozukara, E.
    Emmert, S.
    Slor, H.
    Busch, D. B.
    Baker, C. C.
    DiGiovanna, J. J.
    Tamura, D.
    Seitz, C. S.
    Gratchev, A.
    Wu, W. H.
    Chung, K. Y.
    Chung, H. J.
    Azizi, E.
    Woodgate, R.
  2. Author Address

    Inui, Hiroki, Oh, Kyu-Seon, Nadem, Carine, Ueda, Takahiro, Khan, Sikandar C.; DiGiovanna, John J.; Tamura, Deborah, Kraemer, Kenneth H.] NCI, DNA Repair Sect, Basic Res Lab, Ctr Canc Res, Bethesda, MD 20892 USA. [Metin, Ahmet] Ankara Ataturk Res & Training Hosp, Dermatol Clin, Ankara, Turkey. [Gozukara, Engm] Yeditepe Univ, Sch Med, Dept Med Biol & Genet, Istanbul, Turkey. [Emmert, Steffen] Univ Gottingen, Dept Dermatol, Gottingen, Germany. [Slor, Hanoch] Tel Aviv Univ, Sch Med, Dept Human Genet, IL-69978 Tel Aviv, Israel. [Busch, David B.] Armed Forces Inst Pathol, Washington, DC 20306 USA. [Baker, Carl C.] NIAMS Extramural Program, Bethesda, MD USA. [DiGiovanna, John J.] Brown Univ, Warren Alpert Sch Med, Dept Dermatol, Div Dematopharmacol, Providence, RI 02912 USA. [Seitz, Cornelia S.] Univ Wurzburg, Dept Dermatol, D-8700 Wurzburg, Germany. [Gratchev, Alexei] Univ Heidelberg, Univ Med Ctr Mannheim, Dept Dermatol, D-6800 Mannheim, Germany. [Wu, Wen Hao, Chung, Kee Yang, Chung, Hye Jin] Yonsei Univ, Coll Med, Cutaneous Biol Res Inst, Dept Dermatol, Seoul, South Korea. [Azizi, Esther] Tel Aviv Univ, Sch Med, Dept Dermatol, IL-69978 Tel Aviv, Israel. [Woodgate, Roger] NICHHD, Lab Genom Integr, Bethesda, MD 20892 USA. [Schneider, Thomas D.] NCI, Nanobiol Program, Canc Res Ctr, Frederick, MD 21701 USA.
    1. Year: 2008
  1. Journal: Journal of Investigative Dermatology
    1. 128
    2. 8
    3. Pages: 2055-2068
  2. Type of Article: Article
  1. Abstract:

    Xeroderma pigmentosum-variant (XP-V) patients have sun sensitivity and increased skin cancer risk. Their cells have normal nucleotide excision repair, but have defects in the POLH gene encoding an error-prone polymerase, DNA polymerase eta (pol eta). To survey the molecular basis of XP-V worldwide, we measured pol eta protein in skin fibroblasts from putative XP-V patients (aged 8-66 years) from 10 families in North America, Turkey, Israel, Germany, and Korea. Pol eta was undetectable in cells from patients in eight families, whereas two showed faint bands. DNA sequencing identified 10 different POLH mutations. There were two splicing, one nonsense, five frameshift (3 deletion and 2 insertion), and two missense mutations. Nine of these mutations involved the catalytic domain. Although affected siblings had similar clinical features, the relation between the clinical features and the mutations was not clear. POLH mRNA levels were normal or reduced by 50% in three cell strains with undetectable levels of pol eta protein, indicating that nonsense-mediated message decay was limited. We found a wide spectrum of mutations in the POLH gene among XP-V patients in different countries, suggesting that many of these mutations arose independently.

    See More

External Sources

  1. PMID: 18368133

Library Notes

  1. No notes added.
NCI at FrederickClose Button

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel